SCHEMBL7033080

SCHEMBL7033080

O=Cc1sccc1-c1ccc(NC(=O)c2ccc(Cl)cc2Cl)c(C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 6/20 0.56
▸ PPARA Q07869 4/20 0.56
▸ ANO1 Q5XXA6 1/20 0.48
▸ SERPINE1 P05121 4/20 0.48
▸ PRSS12 P56730 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ AKR1C4 P17516 1/20 0.43
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ AKR1C1 Q04828 1/20 0.43
▸ PYGL P06737 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ APOBEC3A P31941 1/20 0.42
▸ APOBEC3G Q9HC16 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038545 0.99 PPARG (0.55) PPARGPPARAANO1SERPINE1PRSS12
Lithium Ion SCHEMBL7038537 0.90 PPARG (0.64) PPARGPPARAANO1KMT2AMEN1
SCHEMBL7038688 0.89 PPARG (0.48) PPARGPPARAANO1TP53KDM4E
SCHEMBL7166079 0.83 PPARG (0.45) PPARGPPARAANO1TP53PYGL
SCHEMBL7038137 0.82 PPARG (0.68) PPARGPPARAANO1SERPINE1TP53
SCHEMBL7040866 0.81 PPARG (0.67) PPARGPPARAANO1SERPINE1TP53
SCHEMBL1307242 0.80 PPARG (0.81) PPARGPPARASERPINE1TP53KDM4E
SCHEMBL7037046 0.78 PPARG (0.62) PPARGPPARASERPINE1TP53KDM4E
SCHEMBL7038130 0.77 SERPINE1 (0.70) PPARGPPARASERPINE1TP53KDM4E
SCHEMBL7040256 0.77 PPARG (0.80) PPARGPPARAANO1SERPINE1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 — — US claimed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 — — WO claimed
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 — — US disclosed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885ANO1 3306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback